Kramer Score, an Evidence of Its Use in Accordance with Indonesian Hyperbilirubinemia Published Guideline

<b>Background:</b> In some hospitals in low/middle-income countries, methods to determine the bilirubin level in newborn infants are unavailable and based on a clinical evaluation, namely a clinical score designed by Kramer. In this study, we evaluated if this score can be used to identi...

Full description

Bibliographic Details
Main Authors: Mahendra Tri Arif Sampurna, Muhammad Pradhika Mapindra, Muhammad Pradhiki Mahindra, Kinanti Ayu Ratnasari, Siti Annisa Dewi Rani, Kartika Darma Handayani, Dina Angelika, Agus Harianto, Martono Tri Utomo, Risa Etika, Pieter J. J. Sauer
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Environmental Research and Public Health
Subjects:
Online Access:https://www.mdpi.com/1660-4601/18/11/6173
id doaj-915231e29da04439ab4f589f7874ff3c
record_format Article
spelling doaj-915231e29da04439ab4f589f7874ff3c2021-06-30T23:31:55ZengMDPI AGInternational Journal of Environmental Research and Public Health1661-78271660-46012021-06-01186173617310.3390/ijerph18116173Kramer Score, an Evidence of Its Use in Accordance with Indonesian Hyperbilirubinemia Published GuidelineMahendra Tri Arif Sampurna0Muhammad Pradhika Mapindra1Muhammad Pradhiki Mahindra2Kinanti Ayu Ratnasari3Siti Annisa Dewi Rani4Kartika Darma Handayani5Dina Angelika6Agus Harianto7Martono Tri Utomo8Risa Etika9Pieter J. J. Sauer10Neonatology Division, Department of Pediatrics, Dr. Soetomo Academic Teaching Hospital, Faculty of Medicine, Universitas Airlangga, Surabaya 60285, IndonesiaNeonatal Research Group Surabaya, Faculty of Medicine, Universitas Airlangga, Surabaya 60285, IndonesiaNeonatal Research Group Surabaya, Faculty of Medicine, Universitas Airlangga, Surabaya 60285, IndonesiaNeonatal Research Group Surabaya, Faculty of Medicine, Universitas Airlangga, Surabaya 60285, IndonesiaNeonatal Research Group Surabaya, Faculty of Medicine, Universitas Airlangga, Surabaya 60285, IndonesiaNeonatology Division, Department of Pediatrics, Dr. Soetomo Academic Teaching Hospital, Faculty of Medicine, Universitas Airlangga, Surabaya 60285, IndonesiaNeonatology Division, Department of Pediatrics, Dr. Soetomo Academic Teaching Hospital, Faculty of Medicine, Universitas Airlangga, Surabaya 60285, IndonesiaNeonatology Division, Department of Pediatrics, Dr. Soetomo Academic Teaching Hospital, Faculty of Medicine, Universitas Airlangga, Surabaya 60285, IndonesiaNeonatology Division, Department of Pediatrics, Dr. Soetomo Academic Teaching Hospital, Faculty of Medicine, Universitas Airlangga, Surabaya 60285, IndonesiaNeonatology Division, Department of Pediatrics, Dr. Soetomo Academic Teaching Hospital, Faculty of Medicine, Universitas Airlangga, Surabaya 60285, IndonesiaDepartment of Pediatrics, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, 9713GZ Groningen, The Netherlands<b>Background:</b> In some hospitals in low/middle-income countries, methods to determine the bilirubin level in newborn infants are unavailable and based on a clinical evaluation, namely a clinical score designed by Kramer. In this study, we evaluated if this score can be used to identify those infants that need phototherapy. <b>Method:</b> Infants admitted between November 2018 and June 2019 to three hospitals in Surabaya, Indonesia were included. The jaundice intensity was scored using the Kramer score. Blood was sampled for total serum bilirubin (TSB) measurement. The infants were categorized into Treatment Needed (TN) group when treatment with phototherapy was indicated and the No Treatment Needed (NTN) group when phototherapy was not indicated, based on the Indonesian Guideline for hyperbilirubinemia. <b>Result:</b> A total of 280 infants with a mean birth weight of 2744.6 ± 685.8 g and a gestational age of 37.3 ± 2.3 weeks were included. Twenty-seven of 113 (24%) infants with Kramer score 2 needed phototherapy, compared with 41 of 90 (46%) infants with score 3 and 20 of 28 (71%) of infants with score 4. The percentage of infants that needed phototherapy was higher with decreasing gestational age. <b>Conclusion:</b> The Kramer score is an invalid method to distinguish between those infants needing phototherapy and those infants where this treatment is not indicated.https://www.mdpi.com/1660-4601/18/11/6173hyperbilirubinemiaKramer scoreIndonesia guidelinephototherapyreliability
collection DOAJ
language English
format Article
sources DOAJ
author Mahendra Tri Arif Sampurna
Muhammad Pradhika Mapindra
Muhammad Pradhiki Mahindra
Kinanti Ayu Ratnasari
Siti Annisa Dewi Rani
Kartika Darma Handayani
Dina Angelika
Agus Harianto
Martono Tri Utomo
Risa Etika
Pieter J. J. Sauer
spellingShingle Mahendra Tri Arif Sampurna
Muhammad Pradhika Mapindra
Muhammad Pradhiki Mahindra
Kinanti Ayu Ratnasari
Siti Annisa Dewi Rani
Kartika Darma Handayani
Dina Angelika
Agus Harianto
Martono Tri Utomo
Risa Etika
Pieter J. J. Sauer
Kramer Score, an Evidence of Its Use in Accordance with Indonesian Hyperbilirubinemia Published Guideline
International Journal of Environmental Research and Public Health
hyperbilirubinemia
Kramer score
Indonesia guideline
phototherapy
reliability
author_facet Mahendra Tri Arif Sampurna
Muhammad Pradhika Mapindra
Muhammad Pradhiki Mahindra
Kinanti Ayu Ratnasari
Siti Annisa Dewi Rani
Kartika Darma Handayani
Dina Angelika
Agus Harianto
Martono Tri Utomo
Risa Etika
Pieter J. J. Sauer
author_sort Mahendra Tri Arif Sampurna
title Kramer Score, an Evidence of Its Use in Accordance with Indonesian Hyperbilirubinemia Published Guideline
title_short Kramer Score, an Evidence of Its Use in Accordance with Indonesian Hyperbilirubinemia Published Guideline
title_full Kramer Score, an Evidence of Its Use in Accordance with Indonesian Hyperbilirubinemia Published Guideline
title_fullStr Kramer Score, an Evidence of Its Use in Accordance with Indonesian Hyperbilirubinemia Published Guideline
title_full_unstemmed Kramer Score, an Evidence of Its Use in Accordance with Indonesian Hyperbilirubinemia Published Guideline
title_sort kramer score, an evidence of its use in accordance with indonesian hyperbilirubinemia published guideline
publisher MDPI AG
series International Journal of Environmental Research and Public Health
issn 1661-7827
1660-4601
publishDate 2021-06-01
description <b>Background:</b> In some hospitals in low/middle-income countries, methods to determine the bilirubin level in newborn infants are unavailable and based on a clinical evaluation, namely a clinical score designed by Kramer. In this study, we evaluated if this score can be used to identify those infants that need phototherapy. <b>Method:</b> Infants admitted between November 2018 and June 2019 to three hospitals in Surabaya, Indonesia were included. The jaundice intensity was scored using the Kramer score. Blood was sampled for total serum bilirubin (TSB) measurement. The infants were categorized into Treatment Needed (TN) group when treatment with phototherapy was indicated and the No Treatment Needed (NTN) group when phototherapy was not indicated, based on the Indonesian Guideline for hyperbilirubinemia. <b>Result:</b> A total of 280 infants with a mean birth weight of 2744.6 ± 685.8 g and a gestational age of 37.3 ± 2.3 weeks were included. Twenty-seven of 113 (24%) infants with Kramer score 2 needed phototherapy, compared with 41 of 90 (46%) infants with score 3 and 20 of 28 (71%) of infants with score 4. The percentage of infants that needed phototherapy was higher with decreasing gestational age. <b>Conclusion:</b> The Kramer score is an invalid method to distinguish between those infants needing phototherapy and those infants where this treatment is not indicated.
topic hyperbilirubinemia
Kramer score
Indonesia guideline
phototherapy
reliability
url https://www.mdpi.com/1660-4601/18/11/6173
work_keys_str_mv AT mahendratriarifsampurna kramerscoreanevidenceofitsuseinaccordancewithindonesianhyperbilirubinemiapublishedguideline
AT muhammadpradhikamapindra kramerscoreanevidenceofitsuseinaccordancewithindonesianhyperbilirubinemiapublishedguideline
AT muhammadpradhikimahindra kramerscoreanevidenceofitsuseinaccordancewithindonesianhyperbilirubinemiapublishedguideline
AT kinantiayuratnasari kramerscoreanevidenceofitsuseinaccordancewithindonesianhyperbilirubinemiapublishedguideline
AT sitiannisadewirani kramerscoreanevidenceofitsuseinaccordancewithindonesianhyperbilirubinemiapublishedguideline
AT kartikadarmahandayani kramerscoreanevidenceofitsuseinaccordancewithindonesianhyperbilirubinemiapublishedguideline
AT dinaangelika kramerscoreanevidenceofitsuseinaccordancewithindonesianhyperbilirubinemiapublishedguideline
AT agusharianto kramerscoreanevidenceofitsuseinaccordancewithindonesianhyperbilirubinemiapublishedguideline
AT martonotriutomo kramerscoreanevidenceofitsuseinaccordancewithindonesianhyperbilirubinemiapublishedguideline
AT risaetika kramerscoreanevidenceofitsuseinaccordancewithindonesianhyperbilirubinemiapublishedguideline
AT pieterjjsauer kramerscoreanevidenceofitsuseinaccordancewithindonesianhyperbilirubinemiapublishedguideline
_version_ 1721351127506616320